Novo Nordisk A/S

NVO | NYSE

Price Alert Chart Builder DCF Calculator

$43.24

+$0.05 (+0.12%)

At close: Sep 18, 2026, 4:00 PM ET

$41.12

-$2.12 (-4.90%)

Pre-market: Sep 21, 2026, 8:57 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	309.06B	290.4B	232.26B	176.95B	140.8B	126.95B
Cost of Revenue	58.79B	44.52B	35.77B	28.45B	23.66B	20.93B
Gross Profit	250.28B	245.88B	196.5B	148.51B	117.14B	106.01B
Operating Income	127.66B	128.34B	102.57B	74.81B	58.64B	54.13B
Interest Income	1.27B	1.84B	1.07B	239M	231M	337M
Pretax Income	130.54B	127.19B	104.67B	69.06B	59.08B	53.13B
Net Income	102.43B	100.99B	83.68B	55.53B	47.76B	42.14B
Selling & General & Admin	70.28B	67.38B	61.6B	50.68B	41.06B	36.89B
Research & Development	52.04B	48.06B	32.44B	24.05B	17.77B	15.46B
Other Expenses	300M	2.1B	-119M	-1.03B	-332M	-460M
Operating Expenses	122.62B	117.54B	93.92B	73.7B	58.5B	51.89B
Interest Expense	4.21B	1.64B	542M	378M	289M	390M
Selling & Marketing Expenses	64.31B	62.1B	56.74B	46.22B	37.01B	32.93B
Cost & Expenses	181.41B	162.06B	129.69B	102.15B	82.16B	72.82B
Income Tax Expense	28.11B	26.2B	20.99B	13.54B	11.32B	10.99B
Shares Outstanding (Basic)	4.45B	4.45B	4.48B	4.53B	4.59B	4.67B
Shares Outstanding (Diluted)	4.45B	4.46B	4.49B	4.54B	4.61B	4.68B
EPS (Basic)	23.06	22.67	18.67	12.26	10.40	9.03
EPS (Diluted)	23.03	22.63	18.62	12.22	10.37	9.01
EBITDA	156.73B	147.94B	114.63B	76.8B	65.39B	59.27B
EBIT	134.75B	128.83B	105.22B	69.44B	59.37B	53.52B
Depreciation & Amortization	21.98B	19.11B	9.41B	7.36B	6.03B	5.75B